Sorted By:

Relevance


High Coinsurance on Specialty Tiers

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/high-coinsurance-on-specialty-tiers

Chronic Conditions Prevalence in Older Americans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/chronic-conditions-prevalence-in-older-americans

Why Innovative Biopharmaceutical Companies are Different

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/why-innovative-biopharmaceutical-companies-are-different

Colon Cancer Case Study: Personalized Treatment vs. One-Size-Fits-All Standards

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/colon-cancer-case-study-personalized-treatment-vs-one-size-fits-all-standards

40% or More Coinsurance for Medicines on Health Insurance Exchange Plans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/40-or-more-coinsurance-for-medicines-on-health-insurance-exchange-plans

Medicare Monday: How Part D Helps Parkinson’s Patients

PhRMA  |  Graphic

A recent study found Part D enrollees with higher adherence to treatment for the disease and longer duration of therapy saw decreases in the use of other health care services and expenses. Specifically, compared to patients...
https://www.phrma.org/graphic/medicare-monday-how-part-d-helps-parkinson-s-patients

Average Copays for Prescription Medicines under Health Insurance Exchanges

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/average-copays-for-prescription-medicines-under-health-insurance-exchanges

Costs Are Rising for Parkinson's Disease

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/costs-are-rising-for-parkinson-s-disease

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

PhRMA  |  Blog Post

The study adds to a large body of evidence that shows patients could lose out under these short-sighted proposals.
http://catalyst.phrma.org/medicare-monday-how-government-price-setting-in-part-d-could-reduce-innovation-shorten-life-expectancy-for-beneficiaries

Distribution of Charity Care Among DSH Hospitals With More Than One Contract Phramacy

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/distribution-of-charity-care-among-dsh-hospitals-with-more-than-one-contract-phramacy

New report portrays flourishing pipeline

PhRMA  |  Blog Post

View the report, summary and graphics of the report here.  
http://catalyst.phrma.org/new-report-portrays-flourishing-pipeline

Local Impact: Hepatitis C and Medicaid spending

PhRMA  |  Blog Post

  Compared to older treatments, this descriptive analysis provides early evidence to suggest that the new generation of hepatitis C medicines, which have cure rates of more than 90 percent, benefit patients and could potentially reduce the use and costs of some Medicaid services.
http://catalyst.phrma.org/local-impact-hepatitis-c-and-medicaid-spending

Resources for understanding the dangers of drug importation

PhRMA  |  Blog Post

To better understand the realities of drug importation from Canada, check out our graphic and read our .phrma.org/case-study-how-one-online-pharmacy-knowingly-endangered-u.s.
http://catalyst.phrma.org/resources-for-understanding-the-dangers-of-drug-importation

Case Study: How one online pharmacy knowingly endangered U.S. consumers

PhRMA  |  Blog Post

There are a number of ways medicines from overseas can be corrupted, and the increasing sophistication of counterfeiters and overseas drug sellers makes it hard to detect counterfeit or adulterated medicines – even for experts.
http://catalyst.phrma.org/case-study-how-one-online-pharmacy-knowingly-endangered-u.s.-consumers

Medicines in Development for Older Americans 2013 Report

PhRMA  |  Report

  With the aging population and life expectancy climbing, higher rates of chronic diseases remain a major challenge for our health care system.
https://www.phrma.org

Medicare Monday: Negotiation in Medicare Part D works

PhRMA  |  Blog Post

Across drug classes widely used in Part D, the report found Medicare Part D plans receive an average 35.3 percent discount from manufacturer list prices.
http://catalyst.phrma.org/medicare-monday-negotiation-in-medicare-part-d-works

The risks of counterfeit imported medicines

PhRMA  |  Blog Post

Get the facts about drug importation here.
http://catalyst.phrma.org/the-risks-of-counterfeit-imported-medicines

Fact Check Friday: The truth about drug importation and patient safety

PhRMA  |  Blog Post

Get the facts about drug importation here.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-drug-importation-and-patient-safety

Burden on Patients: Access to Medicines in Exchange Plans

PhRMA  |  Blog Post

Check out the 2015 Burden on Patients series posts highlighted below: Mental Health Disorders Blog: Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans Graphic: Utilization Management Applied to Mental Health Medicines Fact Sheet: Access to Mental Health Medicines in Exchange Plans   HIV/AIDS Blog: Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans Graphic: Placing All HIV Medicines on a Specialty Tier Could Be a Barrier to Access in Health Insurance Exchange Plans Fact Sheet: Access to HIV/AIDS Medicines in Exchange Plans  Oncology Blog: Burden on Patients: Questions on Access to Cancer Medicines in Health Exchange Plans Graphic: Utilization Management Applied to Oncology Innovator Medicines Fact Sheet: Access to Oncology Medicines in Exchange Plans Asthma Blog: Burden on Patients: 5 Questions on Access to Asthma Medicines in Health Exchange Plans Graphic: Utilization Management for Asthma Medicines Could Be a Barrier to Access in Health Insurance Exchange Plans Fact Sheet: Access to Asthma Medicines in Exchange Plans Diabetes Blog: Burden on Patients: 5 Questions on Access to Diabetes Medicines in Health Exchange Plans Graphic: Utilization Management for Diabetes Medicines Could Be a Barrier to Access in Health Insurance Exchange Plans Fact Sheet: Access to Diabetes Medicines in Exchange Plans Multiple Sclerosis Blog: Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans Fact Sheet: Access to Multiple Sclerosis Medicines in Exchange Plans Rheumatoid Arthritis Blog: Burden on Patients: 5 Questions on access to rheumatoid arthritis medicines in health exchange plans Graphic: Increasingly Placing Rheumatoid Arthritis Medicines on a Specialty Tier Could Be a Barrier to Access Fact Sheet: Access to Rheumatoid Arthritis Medicines in Exchange Plans
http://catalyst.phrma.org/burden-on-patients-access-to-medicines-in-exchange-plans

Medicines in Development for Parkinson's Disease 2014 Report

PhRMA  |  Report

  Understanding Parkinson's Disease: Living, Working & the Economy Each year, approximately 60,000 Americans are diagnosed with Parkinson’s disease, and incidence increases with age.
https://www.phrma.org/report/medicines-in-development-for-parkinson-s-disease-2014-report

Director - IP and Innovation Policy

PhRMA  |  PhRMA Career

Prepare/develop slide decks, chart-packs, info-graphics, and other presentations on issues such as STEM education related to the importance of IP to innovation by the biopharma industry.
https://www.phrma.org/careers/director-ip-and-innovation-policy

Part B

PhRMA  |  From PhRMA

Medicare pays a market-based rate for Part B medicines. 
https://www.phrma.org/advocacy/medicare/partb

New Report Shows How Supply Chain Shapes Brand-Name Medicine Prices

PhRMA  |  Press Release

View the full report here and patient examples here.
https://www.phrma.org

Senior Director - IP and Innovation Policy

PhRMA  |  PhRMA Career

Prepare/develop slide decks, chart-packs, info-graphics, and other presentations on issues such as STEM education related to the importance of IP to innovation by the biopharma industry. 
https://www.phrma.org

Burden on Patients: Looking Ahead

PhRMA  |  Blog Post

Asthma Blog: Access to Asthma Medicine and the Risk of Going Without By the Numbers Graphic: Asthma Fact Sheet: Access to Asthma Medicines in Exchanges Rheumatoid Arthritis Blog: Preserving the ‘New Normal’ for Patients with Rheumatoid Arthritis By the Numbers Graphic: Rheumatoid Arthritis Fact Sheet: Access to Rheumatoid Arthritis Medicines in Exchanges Diabetes Blog: Prescription Management is Critical for Diabetes Patients By the Numbers Graphic: Diabetes Fact Sheet: Access to Diabetes Medicines in Exchanges HIV/AIDS  Blog: Two Steps Forward and One Step Back for HIV/AIDS Patients By the Numbers Graphic: HIV/AIDS Fact Sheet: Access to HIV/AIDS Medicines in Exchanges Mental Health Disorders Blog: Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines By The Numbers Graphic: Mental Health  Fact Sheet: Access to Mental Health Medicines in Exchanges Multiple Sclerosis Blog: One-Size-Fits-All Approach to Treating Multiple Sclerosis Hurts Patients By the Numbers Graphic: MS Fact Sheet: Access to Multiple Sclerosis Medicines in Exchanges Oncology Blog: Limiting Access to Necessary Medicines Threatens Hope for Oncology Patients By the Numbers Graphic: Oncology Fact Sheet: Access to Oncology Medicines in Exchanges
http://catalyst.phrma.org/burden-on-patients-looking-ahead-2014

You have reviewed the first 150 results out of 171. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next